Shares of Teladoc Health Inc. (TDOC) soared over 11% in pre-market trading on Tuesday, October 31, 2024, fueled by the virtual healthcare provider's better-than-expected third-quarter results and upbeat full-year guidance.
For the three months ended September 30, 2024, Teladoc reported revenue of $640.5 million, down 3% year-over-year but exceeding analysts' estimates of $631.2 million. The company's Integrated Care segment, which includes general medical, expert services, and chronic condition management, saw revenue increase 2% to $383.7 million, driven by strong growth in visit revenue and increased membership.
Despite the overall revenue decline, Teladoc's net loss narrowed to $33.3 million, or $0.19 per share, beating analysts' expectations of a $0.29 per share loss. The company's adjusted EBITDA for the quarter was $83.3 million, down 6% from the prior year but still reflecting profitability.
Looking ahead, Teladoc raised its full-year 2024 revenue growth guidance to the low to mid-single digits, up from its previous forecast. The company also expects its Integrated Care segment's adjusted EBITDA margin to be between 14.9% and 15.3%, an improvement from its prior outlook.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.